Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Alliance Grants

Université Laval

$50,000.00

Effects of high polyphenol doses on the replication of COVID-19 in vitro_x000d_

FY 2020-21

Summary
The SARS-CoV-2 outbreak in causing an unprecedented global sanitary crisis. The contagious virus has a lethal rate of close to 2% death in the overall affected population and more than 15 % in elderly people. To date, there are no medications or vaccines approved for the treatment of this viral disease. This RNA virus is associated to SARS-CoV-1, a related virus which emerged in 2002-03 in China, but has distinct features provoking specific morbid symptoms. In the context of the actual pandemic, it is urgent to revisit the arsenal of already developed synthetic drugs and natural molecules from the traditional pharmacopeia with potential action against the virus. The reclassification of a molecule to a new anti-viral use can provide a rapid approach to develop and recommend a drug since its dosage, side effects, formulation and toxicity are already known. Among the pharmacopeia of natural medicinal plants, flavonoids appear promising to fight SARS-CoV-2. Indeed, they display antiviral activity against a number of viruses such as influenza, Zika, Ebola, hepatitis, HIV and many others. Epigallocatechin gallate, quercetin, hesperidin, all flavonoids, are candidate molecules for further activity testing owing to their high-docking capacity on important virus protein binding sites. Noteworthy is the fact that the first three molecules are found in high concentrations in green tea, onions, and citrus respectively. They can be extracted efficiently using available technologies with relatively simple protocol adaptation. Most interestingly, the toxicology of these products has been amply studied and Health Canada already has monographies describing their accepted traditional use, toxicity and side effects. We hypothesize that flavonoids have an inhibitory action preventing the replication of SARS-CoV-2 in Vero cells and that it is possible to develop efficient extraction protocols for the bioactive molecules identified during the in vitro screening phases. We will in particular evaluate, 7 polyphenols (EGCG, quercetin, isoquercetin, hesperidin, catechin, proanthocyanidins, catechins, ferulic acid) on replication of SARS-CoV-2 in vitro and develop protocols for the extraction of these molecules from different sources of raw product. _x000d_La pandémie de Sars-CoV 2 est à l'origine d'une crise sanitaire sans précédent. On estime le taux de mortalité associé à la contagion à près de 2 % dans la population entière, mais pourrait s'élever à près de 14 % chez les personnes ägées. Il n'existe à c
Program
Alliance Grants
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
552135-2020
Name nom
Desjardins, Yves
Department département
Phytologie
Organization id
51
Institution établissement
Université Laval
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2020
Competition year année de concours
2020
Award amount
50000
Program id
ALLRP
Program name en
Alliance Grants
Program name fr
Subventions Alliance
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
504
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Human pharmaceuticals
Area of application fr
Produits pharmaceutiques administrables à l'homme
Research subject code
6404
Research subject group en
Life sciences research related to human health and disease
Research subject group fr
Sciences de la vie liées à la santé publique et aux maladies humaines
Research subject en
Pharmacology
Research subject fr
Pharmacologie
Installment
inst:1 - 1
Partie
1
Nb partie
1
Application title
Effects of high polyphenol doses on the replication of COVID-19 in vitro_x000d_
Keyword
NSERC
Application summary
The SARS-CoV-2 outbreak in causing an unprecedented global sanitary crisis. The contagious virus has a lethal rate of close to 2% death in the overall affected population and more than 15 % in elderly people. To date, there are no medications or vaccines approved for the treatment of this viral disease. This RNA virus is associated to SARS-CoV-1, a related virus which emerged in 2002-03 in China, but has distinct features provoking specific morbid symptoms. In the context of the actual pandemic, it is urgent to revisit the arsenal of already developed synthetic drugs and natural molecules from the traditional pharmacopeia with potential action against the virus. The reclassification of a molecule to a new anti-viral use can provide a rapid approach to develop and recommend a drug since its dosage, side effects, formulation and toxicity are already known. Among the pharmacopeia of natural medicinal plants, flavonoids appear promising to fight SARS-CoV-2. Indeed, they display antiviral activity against a number of viruses such as influenza, Zika, Ebola, hepatitis, HIV and many others. Epigallocatechin gallate, quercetin, hesperidin, all flavonoids, are candidate molecules for further activity testing owing to their high-docking capacity on important virus protein binding sites. Noteworthy is the fact that the first three molecules are found in high concentrations in green tea, onions, and citrus respectively. They can be extracted efficiently using available technologies with relatively simple protocol adaptation. Most interestingly, the toxicology of these products has been amply studied and Health Canada already has monographies describing their accepted traditional use, toxicity and side effects. We hypothesize that flavonoids have an inhibitory action preventing the replication of SARS-CoV-2 in Vero cells and that it is possible to develop efficient extraction protocols for the bioactive molecules identified during the in vitro screening phases. We will in particular evaluate, 7 polyphenols (EGCG, quercetin, isoquercetin, hesperidin, catechin, proanthocyanidins, catechins, ferulic acid) on replication of SARS-CoV-2 in vitro and develop protocols for the extraction of these molecules from different sources of raw product. _x000d_La pandémie de Sars-CoV 2 est à l'origine d'une crise sanitaire sans précédent. On estime le taux de mortalité associé à la contagion à près de 2 % dans la population entière, mais pourrait s'élever à près de 14 % chez les personnes ägées. Il n'existe à c